reports
Agilent Presents Solutions Innovation Research Awards to Aarhus Univer...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced Solutions Innovation Research Awards (SIRA) have been presented to Professor Anders Bentien of , Professor Walter Gössler of , and Professor Gregory Offer of . These separate awards recognize their outstanding contributions to battery research. Developing new materials for more efficient and durable batteries is essential to reducing fossil fuel reliance and meeting global energy storage needs. Given the limited supply of critical metals like lithium, it is crucial to focus on pioneering new materials and recovering and reusin...
Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conferenc...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Bob McMahon will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 14, 2025, at 9:45 a.m. Pacific time. A live audio webcast and replay of the presentation will be available on the . About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full ran...
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives Eur...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for (Code SK005). This CDx assay has previously been CE-IVD–marked for sales in the European Union and is now certified in accordance with the new EU Regulation for in vitro diagnostic medical devices (IVDR) 1. PD-L1 IHC 28-8 pharmDx is approved for exclusive use with the advanced staining solution. Agilent’s PD-L1 IHC 28-8 pharmDx (Code SK005) provides clinically relevant information about PD-L1 expression – a critical biomarke...
Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.70 billion for the fourth quarter ended October 31, 2024, an increase of 0.8% reported and a decline of 0.3% core(1) compared to the fourth quarter of 2023. Fourth-quarter GAAP net income was $351 million, or $1.22 per share. This compares with $475 million, or $1.62 per share, in the fourth quarter of fiscal year 2023. Non-GAAP(2) net income was $418 million, or $1.46 per share during the quarter, compared with $404 million or $1.38 per share during the fourth quarter a year ago. “The A...
Agilent Announces New Organizational Structure to Support its Market-F...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced a new organizational structure to accelerate the company’s operational transformation to drive higher growth through a market-focused, customer-centric enterprise strategy. The new structure, including new leadership roles, takes effect immediately. “This is an important step in our transformation to become a nimbler company that puts our customers and our markets first,” said Agilent President and CEO Padraig McDonnell. “It builds on Agilent’s legacy of success and evolves our business to further stre...
Agilent Increases Cash Dividend to 24.8 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies, Inc. (NYSE: A) today announced the company has increased its quarterly dividend to 24.8 cents per share of common stock, a 5% increase over the previous dividend. The quarterly dividend will be paid on Jan. 22, 2025, to all shareholders of record as of the close of business on Dec. 31, 2024. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory te...
Agilent 2024 Early Career Professor Award Presented to Adeyemi Adeleye
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) announced today that , has received the Agilent 2024 Early Career Professor Award for his contribution to environmental health and sustainability, developing green analytical technologies, methods, or laboratory working environments. Dr. Adeleye is an assistant professor in the Department of Earth and Environmental Engineering at . The 2024 award focused on contributions to academic research in sustainability and green chemistry. Dr. Adeleye’s research focuses on improving environmental health and sustainability through green approaches, and ...
Agilent Ranks No. 11 on Fortune’s List of Best Workplaces in the World
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the company has been named to , ranking no. 11 among 25 companies. This press release features multimedia. View the full release here: (Photo: Business Wire) The list is based on 7.4 million responses to the Great Place to Work survey, which represents the experiences of 20 million employees worldwide. The survey assesses employee satisfaction in key areas, from credibility and respect to fairness and camaraderie. “Being named one of the best workplaces in the world is a tremendous achievement. Thank ...
Agilent Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) announces the new . This easy and streamlined end-to-end solution makes sophisticated analysis of mitochondrial function available to researchers of all skill levels. With this cost-effective and versatile kit, researchers can easily incorporate functional assessment of relative mitochondrial respiration into their cell physiology and disease pathology studies. Mitochondria are central to energy production processes that drive cellular activity, and mitochondrial dysfunction is linked to numerous diseases and conditions. The Mito-rOCR assay e...
Agilent Presents Solutions Innovation Research Awards to Institut Nati...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced that at Institut National de la Recherche Scientifique (INRS), and at the University of Southern California (USC) are recipients of an Agilent Solutions Innovation Research Award (SIRA). The honorees will receive separate awards on behalf of their institutions in recognition of their research in cell and gene therapy. Developing new cell and gene therapies is increasingly vital amid the heightened focus on personalized treatments in the healthcare industry. In recognition of this growing need, Agilent will grant two SIRA awar...
Agilent Revolutionizes HPLC with the Launch of the Agilent Infinity II...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions. These are the first HPLC systems on the market to feature the new Agilent InfinityLab Assist Technology, offering enhanced, built-in system assistance capabilities. This technology allows labs to focus more on achieving results rather than on daily operation and maintenance tasks. With the introduction of these...
Agilent to Announce Fourth-Quarter Fiscal Year 2024 Financial Results ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2024 after the stock market closes on Monday, Nov. 25. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST. To join the listen-only conference call webcast, click the link on the of Agilent’s investor relations website. A recording of the call also will be available on the website for 90 days. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laborat...
Agilent to Host Analyst and Investor Day on Dec. 17, 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) will host an Analyst and Investor Day in New York City on Tuesday, Dec. 17, at 10 a.m. ET. CEO Padraig McDonnell, CFO Bob McMahon, and other senior business leaders will present information regarding Agilent’s strategy, businesses, and long-term financial outlook. The event will conclude with a Q&A session. This in-person event is by invitation only, but a live webcast will be accessible through Agilent’s . A replay of the event will be available for at least 60 days. About Agilent Technologies Agilent Technologies ...
Agilent Completes Acquisition of BIOVECTRA
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO) that specializes in biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics. This press release features multimedia. View the full release here: (Graphic: Business Wire) All closing conditions are completed, including receipt of regulatory approvals. BIOVECTRA is now part of Agilent’s Diagnostics and Genomics Group. “We are de...
Agilent Announces Cash Dividend of 23.6 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on Oct. 23, 2024, to all shareholders of record as of the close of business on Oct. 1, 2024. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life...
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Med...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- , (NYSE: A) today announced the launch of its in Carpinteria, California, following receipt of California State clinical laboratory license and Clinical Laboratory Improvement Amendments (CLIA) certificate of compliance. These credentials signify that the lab operates in accordance with CLIA regulations, which are federal standards applicable to all U.S. facilities testing human specimens for health assessment, diagnosis, prevention, or treatment of diseases. The CLIA certificate of compliance ensures high standards for accuracy and reliability in labor...
Moody's Ratings assigns Baa1 rating to Agilent's unsecured notes
Moody's Ratings (Moody's) assigned a Baa1 rating to Agilent Technologies, Inc.'s ("Agilent") new senior unsecured notes. There is no change to the company's existing Baa1 senior unsecured rating and Prime-2 commercial paper rating. The rating outlook is stable. We expect that Agilent will use proc...
Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.58 billion for the third quarter ended July 31, 2024, a decline of 5.6% reported and 4.4% core(1) compared to the third quarter of 2023. Third-quarter GAAP net income was $282 million, or $0.97 per share. This compares with $111 million, or $0.38 per share, in the third quarter of fiscal year 2023. Non-GAAP(2) net income was $385 million, or $1.32 per share during the quarter, compared with $422 million or $1.43 per share during the third quarter a year ago. “The Agilent team executed we...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.